跳至主要内容
临床试验/CTRI/2025/10/095781
CTRI/2025/10/095781尚未招募2 期

Clinical Utility of Homoeopathic Medical Repertory by Dr. Robin Murphy in cases of Irritable Bowel Syndrome using IBS-SSS

MUSKAAN BELLANI1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2025年10月21日最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
50
试验地点
1
主要终点
USEFULLNESS OF HOMOEOPATHIC MEDICAL REPERTORY BY DR ROBIN MURPHY IN CASES OF IBS

研究概览

简要总结

This study will evaluate the role of individualized homoeopathic treatment in patients with Irritable Bowel Syndrome (IBS). Patients diagnosed with IBS using the Rome IV criteria will be treated with remedies selected through Murphy’s Homoeopathic Repertory. The effectiveness of treatment will be assessed using the IBS Symptom Severity Score (IBS-SSS). A total of 50 patients between 15–65 years will be included, and follow-up will be done weekly for 18 months. The study aims to measure improvement in symptoms, quality of life, and patient satisfaction, while also identifying commonly indicated homoeopathic remedies for IBS.

研究设计

研究类型
Interventional
分配方式
Na
盲法
None

入排标准

年龄范围
15.00 Year(s) 至 65.00 Year(s)(—)
性别
All

入选标准

  • Patients diagnosed as per ROME’S IV Criteria with IBS, with no major complications or concurrent severe illnesses.

排除标准

  • Patients with anatomical abnormalities , inflammatory bowel diseases, malignancies, or requiring urgent surgical interventions.
  • 2.Subjects under 15 years and above 65 years will be excluded from studies 3.Pregnant or lactating women.

结局指标

主要结局

USEFULLNESS OF HOMOEOPATHIC MEDICAL REPERTORY BY DR ROBIN MURPHY IN CASES OF IBS

时间窗: BASELINE 0 WEEK,4TH WEEK , 3RD MONTH , 6TH MONTH , 9TH MONTH

次要结局

  • 1.IMPROVEMENT IN QUALITY OF LIFE OF PATIENT(Improvemnt in IBSSS Score)

研究者

发起方
MUSKAAN BELLANI
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr Muskaan Bellani

Anand Homeopathic Medical College And Research Institute

研究点 (1)

Loading locations...

相似试验